Imexpharm Corporation (HOSE:IMP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
35,000
0.00 (0.00%)
At close: Jul 24, 2026
Market Cap5.39T -33.0%
Revenue (ttm)2.32T -4.2%
Net Income314.36B +0.7%
EPS2,041.17 +1.4%
Shares Out 154.01M
PE Ratio17.15
Forward PE15.19
Dividend500.00 (1.43%)
Ex-Dividend DateJul 13, 2026
Volume23,506
Open34,900
Previous Close35,000
Day's Range34,850 - 36,000
52-Week Range33,500 - 57,000
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateOct 16, 2026

About Imexpharm

Imexpharm Corporation operates as a pharmaceutical company in Vietnam. The company’s products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements. It is also involved in the import and export. Imexpharm Corporation was founded in 1997 and is headquartered in Cao Lanh, Vietna... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 1,444
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol IMP
Full Company Profile

Financial Performance

In 2025, Imexpharm's revenue was 2.44 trillion, an increase of 10.70% compared to the previous year's 2.21 trillion. Earnings were 304.39 billion, an increase of 10.34%.

Financial Statements